These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11737054)

  • 1. Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemia.
    Orleans-Lindsay JK; Barber LD; Prentice HG; Lowdell MW
    Clin Exp Immunol; 2001 Dec; 126(3):403-11. PubMed ID: 11737054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical study.
    Ingram W; Chan L; Guven H; Darling D; Kordasti S; Hardwick N; Barber L; Mufti GJ; Farzaneh F
    Br J Haematol; 2009 Jun; 145(6):749-60. PubMed ID: 19388935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities.
    Christodoulou I; Ho WJ; Marple A; Ravich JW; Tam A; Rahnama R; Fearnow A; Rietberg C; Yanik S; Solomou EE; Varadhan R; Koldobskiy MA; Bonifant CL
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34896980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients.
    Siegler U; Meyer-Monard S; Jörger S; Stern M; Tichelli A; Gratwohl A; Wodnar-Filipowicz A; Kalberer CP
    Cytotherapy; 2010 Oct; 12(6):750-63. PubMed ID: 20491532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia.
    Yang T; Chen ZZ; Kolb HJ; Buhmann R
    Immunobiology; 2013 Apr; 218(4):548-53. PubMed ID: 22883564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion.
    Xing D; Ramsay AG; Gribben JG; Decker WK; Burks JK; Munsell M; Li S; Robinson SN; Yang H; Steiner D; Shah N; McMannis JD; Champlin RE; Hosing C; Zweidler-McKay PA; Shpall EJ; Bollard CM
    J Immunother; 2010 Sep; 33(7):684-96. PubMed ID: 20664358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
    Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Culture of normal and leukemic bone marrow in interleukin-2: analysis of cell activation, cell proliferation, and cytokine production.
    Klingemann HG; Neerunjun J; Schwulera U; Ziltener HJ
    Leukemia; 1993 Sep; 7(9):1389-93. PubMed ID: 8371589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia.
    Mani R; Rajgolikar G; Nunes J; Zapolnik K; Wasmuth R; Mo X; Byrd JC; Lee DA; Muthusamy N; Vasu S
    Cytotherapy; 2020 Jul; 22(7):369-376. PubMed ID: 32303428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4+ T cells in a subset of cultures.
    Ingram W; Kordasti S; Chan L; Barber LD; Tye GJ; Hardwick N; Mufti GJ; Farzaneh F
    Cancer Immunol Immunother; 2009 Oct; 58(10):1679-90. PubMed ID: 19283381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition.
    Wiernik A; Foley B; Zhang B; Verneris MR; Warlick E; Gleason MK; Ross JA; Luo X; Weisdorf DJ; Walcheck B; Vallera DA; Miller JS
    Clin Cancer Res; 2013 Jul; 19(14):3844-55. PubMed ID: 23690482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cytotoxic lymphocyte subsets against leukemia by stimulation with AML blasts.
    Lotzová E; Savary CA
    Med Oncol Tumor Pharmacother; 1993; 10(1-2):13-9. PubMed ID: 8258990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of highly cytotoxic human natural killer cells for cancer cell therapy.
    Fujisaki H; Kakuda H; Shimasaki N; Imai C; Ma J; Lockey T; Eldridge P; Leung WH; Campana D
    Cancer Res; 2009 May; 69(9):4010-7. PubMed ID: 19383914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia.
    Caruso S; De Angelis B; Del Bufalo F; Ciccone R; Donsante S; Volpe G; Manni S; Guercio M; Pezzella M; Iaffaldano L; Silvestris DA; Sinibaldi M; Di Cecca S; Pitisci A; Velardi E; Merli P; Algeri M; Lodi M; Paganelli V; Serafini M; Riminucci M; Locatelli F; Quintarelli C
    J Hematol Oncol; 2022 Nov; 15(1):163. PubMed ID: 36335396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
    Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
    Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites.
    Brune M; Hansson M; Mellqvist UH; Hermodsson S; Hellstrand K
    Eur J Haematol; 1996 Oct; 57(4):312-9. PubMed ID: 8982295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells differentiated in vitro from cord blood CD34
    Domogala A; Blundell M; Thrasher A; Lowdell MW; Madrigal JA; Saudemont A
    Cytotherapy; 2017 Jun; 19(6):710-720. PubMed ID: 28428057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia.
    Hong CS; Sharma P; Yerneni SS; Simms P; Jackson EK; Whiteside TL; Boyiadzis M
    Sci Rep; 2017 Oct; 7(1):14684. PubMed ID: 29089618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bone marrow microenvironment is a critical player in the NK cell response against acute myeloid leukaemia in vitro.
    Vasold J; Wagner M; Drolle H; Deniffel C; Kütt A; Oostendorp R; Sironi S; Rieger C; Fiegl M
    Leuk Res; 2015 Feb; 39(2):257-62. PubMed ID: 25542695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.